BALTIMORE, March 17 /PRNewswire-USNewswire/ -- The following was issued today by the Greater Baltimore Committee:
Donald C. Fry, president & CEO, Greater Baltimore Committee
140 company owners, executives and researchers from the Baltimore-area bioscience community
The third annual Greater Baltimore Region Bioscience Awards
Tuesday, March 18, 2008
8:00 a.m. / Breakfast & Registration
8:45 - 9:30 a.m. / Awards Program
Renaissance Harborplace Hotel, 202 East Pratt Street, Baltimore, MD 21202
More than 140 leaders from the Baltimore region's bioscience industry and research community will attend a breakfast reception at the Greater Baltimore Committee to honor winners of the 2008 Greater Baltimore Region Bioscience Awards.
This is the third annual awards event presented by the Greater Baltimore Committee, the region's most prominent organization of business and civic leaders, to recognize outstanding achievements in the region's bioscience industry. The Greater Baltimore Committee has made support for the emerging bioscience industry in the region one of its top long-term priorities.
Award winners, to be announced, were selected from among 22 nominations submitted by businesses, bioscience advocates, higher education institutions and government officials.
Awards will be presented in the following categories: Best New Product or Progress Award, Entrepreneurship Award, Leadership in Bioscience Award, and President's Award.
Nominees for this year's awards are:
Best New Product or Progress Award
-- Kris Appel, President & CEO, Encore Path, Inc.
-- Timothy E. Askew, President & CEO, CSA Medical, Inc.
-- James Campbell, M.D., CEO, Arcion Therapeutics
-- William G. Hearl, Ph.D., Founder & President, Immunomic Therapeutics, Inc.
-- Ryan Sysko, Founder & CE
|SOURCE Greater Baltimore Committee|
Copyright©2008 PR Newswire.
All rights reserved